Met Life Investment Management, LLC Puma Biotechnology, Inc. Transaction History

Met Life Investment Management, LLC

$16.5 Billion
Q2 2025

A detailed history of Met Life Investment Management, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,158 shares of PBYI stock, worth $132,259. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,158

Previous 27,121 0.14%

Holding current value

$132,259

Previous $80,000 16.25%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$2.74 - $3.72 $101 - $137	37 Added 0.14%	27,158 $93,000
Q1 2025 May 14, 2025	BUY	$2.76 - $3.88 $74,853 - $105,229	27,121 New	27,121 $80,000
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.83 $32,041 - $63,972	10,973 New	10,973 $35,000
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $21,480 - $27,747	-2,392 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$9.38 - $13.63 $22,436 - $32,602	2,392 New	2,392 $23,000
Q1 2021 Jun 26, 2023	BUY	$9.38 - $13.63 $22,436 - $32,602	2,392 New	2,392 $23.3 Million
Q1 2021 Mar 22, 2023	SELL	$9.38 - $13.63 $106,922 - $155,368	-11,399 Reduced 82.66%	2,392 $23,000
Q1 2021 May 14, 2021	SELL	$9.38 - $13.63 $106,922 - $155,368	-11,399 Reduced 82.66%	2,392 $23,000
Q4 2020 Jun 22, 2023	BUY	$7.78 - $12.13 $107,293 - $167,284	13,791 New	13,791 $141,000
Q3 2020 Jun 26, 2023	BUY	$9.5 - $11.14 $131,014 - $153,631	13,791 New	13,791 $139,000
Q2 2020 May 24, 2024	BUY	$7.01 - $13.24 $96,674 - $182,592	13,791 New	13,791 $144 Million
Q2 2020 Jun 26, 2023	BUY	$7.01 - $13.24 $96,674 - $182,592	13,791 New	13,791 $143,000
Q1 2020 Jul 12, 2023	BUY	$6.28 - $14.57 $86,607 - $200,934	13,791 New	13,791 $116,000
Q4 2019 Jul 12, 2023	BUY	$6.5 - $10.73 $89,641 - $147,977	13,791 New	13,791 $120,000
Q3 2019 Jul 12, 2023	BUY	$8.75 - $12.85 $120,671 - $177,214	13,791 New	13,791 $148,000
Q2 2019 Jul 12, 2023	BUY	$12.3 - $35.76 $169,629 - $493,166	13,791 New	13,791 $175,000
Q1 2019 Jul 13, 2023	BUY	$20.77 - $42.37 $286,439 - $584,324	13,791 New	13,791 $534,000
Q4 2018 Jul 13, 2023	BUY	$20.07 - $46.7 $276,785 - $644,039	13,791 New	13,791 $280,000
Q4 2018 Mar 22, 2023	SELL	$20.07 - $46.7 $146,832 - $341,657	-7,316 Reduced 34.66%	13,791 $280,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $146,832 - $341,657	-7,316 Reduced 34.66%	13,791 $281,000
Q3 2018 Jul 13, 2023	BUY	$41.2 - $59.85 $568,189 - $825,391	13,791 New	13,791 $632,000
Q3 2018 Mar 22, 2023	BUY	$41.2 - $59.85 $869,608 - $1.26 Million	21,107 New	21,107 $967,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $301,419 - $437,862	7,316 Added 53.05%	21,107 $968,000
Q4 2017 Feb 15, 2018	BUY	$93.85 - $132.45 $1.29 Million - $1.83 Million	13,791	13,791 $1.36 Million

Others Institutions Holding PBYI

# of Institutions

121

Shares Held

32.6M

Call Options Held

32.7K

Put Options Held

200

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $222M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Puma Biotechnology, Inc. Transaction History